Key Highlights

  • The fund tracks U.S. manufacturers and distributors of medical equipment.
  • Abbott Laboratories, Intuitive Surgical and Medtronic are the largest holdings.
  • The portfolio holds 49 companies, with a 0.37 percent expense ratio.
  • Net Assets were about $4.1 billion on November 11, 2026.

The iShares U.S. Medical Devices ETF (NYSEARCA:IHI) closed at $58.17 on November 11, 2026, with net assets of about $4.1 billion. The fund seeks to track an index that includes U.S. equities in the medical devices sector, covering manufacturers and distributors of medical equipment. Its portfolio focuses on products used in hospitals, surgical settings and diagnostic laboratories.

Ticker and exchange

IHI, NYSE Arca

Benchmark index

Dow Jones U.S. Select Medical Equipment Index

Net asset value

$58.18 (Nov 11, 2026)

Daily NAV change

Up $0.11 (0.18%)

Net assets

$4,078,104,609

Number of holdings

49

Expense ratio

0.37%

30-day SEC yield

0.83%

Distribution frequency

Quarterly

Fund inception

May 1, 2006

Focus on Medical Equipment

The index behind IHI selects American companies that make and distribute medical devices, from surgical robotics and cardiovascular products to diagnostic instruments. Because the fund is confined to one industry, its movements are closely tied to product approvals, hospital purchasing and reimbursement policies.

The 49 holdings give the portfolio a focused structure. Each company's results therefore carry more weight than they would in a broad healthcare fund.

Largest Positions

Abbott Laboratories accounts for about 17.60 percent of market value, followed by Intuitive Surgical at 14.64 percent and Medtronic at 11.45 percent. IDEXX Laboratories holds roughly 5.41 percent, and Edwards Lifesciences accounts for about 4.83 percent. Becton Dickinson, Stryker, GE HealthCare Technologies, ResMed and Boston Scientific make up most of the remaining top ten positions.

The top three holdings represent more than 40 percent of the fund, which means that developments at these companies can shape overall results to a significant degree.

Trading and Distribution Details

About 1.92 million shares traded on November 11, 2026, compared with a 30-day Average Daily Volume of roughly 3.78 million shares. The 30-day median bid-ask spread was 0.02 percent, and the fund had 70.1 million shares outstanding.

The fund distributes income quarterly, and the September 2026 payment totaled $0.080895 per share. The 30-day SEC Yield was 0.83 percent and the 12-month trailing yield was 0.48 percent, both calculated at the end of October 2026.

Final Word

IHI offers a focused path into U.S. medical device companies, with a 49-company portfolio led by a few large firms. Its 0.37 percent expense ratio and quarterly distribution schedule frame the cost and income structure. The fund's course will continue to depend on product demand, regulatory decisions and hospital spending patterns.